SGMT 8-K 2026-09-30

Sagimet Biosciences Inc. (SGMT) 8-K dated 2026-09-30 — accession 0001193125-26-408224. This URL is the filing, not the SGMT hub.

Sagimet Biosciences Inc. (SGMT) is a biotechnology company listed on NASDAQ.

Sagimet Biosciences Inc. filed a 8-K on 2026-09-30. Accession 0001193125-26-408224.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.

Not investment advice. The SGMT SEC hub lists recent forms. The stock page is the research view.